Cargando…

Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis

BACKGROUND: Imaging may play an important role in identifying high‐risk plaques in patients who have carotid disease and who could benefit from surgical revascularization. We sought to evaluate the cost effectiveness of a decision‐making rule based on the ultrasound imaging assessment of plaque echo...

Descripción completa

Detalles Bibliográficos
Autores principales: Baradaran, Hediyeh, Gupta, Ajay, Anzai, Yoshimi, Mushlin, Alvin I., Kamel, Hooman, Pandya, Ankur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898827/
https://www.ncbi.nlm.nih.gov/pubmed/31645165
http://dx.doi.org/10.1161/JAHA.119.012739
_version_ 1783477034938269696
author Baradaran, Hediyeh
Gupta, Ajay
Anzai, Yoshimi
Mushlin, Alvin I.
Kamel, Hooman
Pandya, Ankur
author_facet Baradaran, Hediyeh
Gupta, Ajay
Anzai, Yoshimi
Mushlin, Alvin I.
Kamel, Hooman
Pandya, Ankur
author_sort Baradaran, Hediyeh
collection PubMed
description BACKGROUND: Imaging may play an important role in identifying high‐risk plaques in patients who have carotid disease and who could benefit from surgical revascularization. We sought to evaluate the cost effectiveness of a decision‐making rule based on the ultrasound imaging assessment of plaque echolucency in patients with asymptomatic carotid stenosis. METHODS AND RESULTS: We used a decision‐analytic model to project lifetime quality‐adjusted life years and costs for 5 stroke prevention strategies: (1) medical therapy only; (2) revascularization if both plaque echolucency and stenosis progression to >90% are present; (3) revascularization only if plaque echolucency is present; (4) revascularization only if stenosis progression >90% is present; or (5) either plaque echolucency or stenosis progression is present. Risks of clinical events, costs, and quality‐of‐life values were estimated based on published sources and the analysis was conducted from a healthcare system perspective for asymptomatic patients with 70% to 89% carotid stenosis at presentation. Patients who did not undergo revascularization had the highest stroke events (17.6%) and lowest life‐years (8.45), while those who underwent revascularization on the basis of either presence of plaque echolucency on ultrasound or progression of carotid stenosis had the lowest stroke events (12.0%) and longest life‐years (14.41). The either plaque echolucency or progression‐based revascularization group had an incremental cost‐effectiveness ratio of $110 000/quality‐adjusted life years compared with the plaque echolucency‐based strategy, which had an incremental cost‐effectiveness ratio of $29 000/quality‐adjusted life years compared with the joint echolucency and progression‐based strategy. CONCLUSIONS: Plaque echolucency on ultrasound can be a cost‐effective tool to identify patients with asymptomatic carotid artery stenosis most likely to benefit from carotid endarterectomy.
format Online
Article
Text
id pubmed-6898827
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68988272019-12-16 Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis Baradaran, Hediyeh Gupta, Ajay Anzai, Yoshimi Mushlin, Alvin I. Kamel, Hooman Pandya, Ankur J Am Heart Assoc Original Research BACKGROUND: Imaging may play an important role in identifying high‐risk plaques in patients who have carotid disease and who could benefit from surgical revascularization. We sought to evaluate the cost effectiveness of a decision‐making rule based on the ultrasound imaging assessment of plaque echolucency in patients with asymptomatic carotid stenosis. METHODS AND RESULTS: We used a decision‐analytic model to project lifetime quality‐adjusted life years and costs for 5 stroke prevention strategies: (1) medical therapy only; (2) revascularization if both plaque echolucency and stenosis progression to >90% are present; (3) revascularization only if plaque echolucency is present; (4) revascularization only if stenosis progression >90% is present; or (5) either plaque echolucency or stenosis progression is present. Risks of clinical events, costs, and quality‐of‐life values were estimated based on published sources and the analysis was conducted from a healthcare system perspective for asymptomatic patients with 70% to 89% carotid stenosis at presentation. Patients who did not undergo revascularization had the highest stroke events (17.6%) and lowest life‐years (8.45), while those who underwent revascularization on the basis of either presence of plaque echolucency on ultrasound or progression of carotid stenosis had the lowest stroke events (12.0%) and longest life‐years (14.41). The either plaque echolucency or progression‐based revascularization group had an incremental cost‐effectiveness ratio of $110 000/quality‐adjusted life years compared with the plaque echolucency‐based strategy, which had an incremental cost‐effectiveness ratio of $29 000/quality‐adjusted life years compared with the joint echolucency and progression‐based strategy. CONCLUSIONS: Plaque echolucency on ultrasound can be a cost‐effective tool to identify patients with asymptomatic carotid artery stenosis most likely to benefit from carotid endarterectomy. John Wiley and Sons Inc. 2019-10-24 /pmc/articles/PMC6898827/ /pubmed/31645165 http://dx.doi.org/10.1161/JAHA.119.012739 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Baradaran, Hediyeh
Gupta, Ajay
Anzai, Yoshimi
Mushlin, Alvin I.
Kamel, Hooman
Pandya, Ankur
Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis
title Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis
title_full Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis
title_fullStr Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis
title_full_unstemmed Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis
title_short Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis
title_sort cost effectiveness of assessing ultrasound plaque characteristics to risk stratify asymptomatic patients with carotid stenosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898827/
https://www.ncbi.nlm.nih.gov/pubmed/31645165
http://dx.doi.org/10.1161/JAHA.119.012739
work_keys_str_mv AT baradaranhediyeh costeffectivenessofassessingultrasoundplaquecharacteristicstoriskstratifyasymptomaticpatientswithcarotidstenosis
AT guptaajay costeffectivenessofassessingultrasoundplaquecharacteristicstoriskstratifyasymptomaticpatientswithcarotidstenosis
AT anzaiyoshimi costeffectivenessofassessingultrasoundplaquecharacteristicstoriskstratifyasymptomaticpatientswithcarotidstenosis
AT mushlinalvini costeffectivenessofassessingultrasoundplaquecharacteristicstoriskstratifyasymptomaticpatientswithcarotidstenosis
AT kamelhooman costeffectivenessofassessingultrasoundplaquecharacteristicstoriskstratifyasymptomaticpatientswithcarotidstenosis
AT pandyaankur costeffectivenessofassessingultrasoundplaquecharacteristicstoriskstratifyasymptomaticpatientswithcarotidstenosis